Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases
March 2, 2026
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready life sciences companies seeking aligned…
February 5, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act:"The introduction of the PASTEUR Act of…
February 3, 2026
WASHINGTON, D.C. –  John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and families living with rare diseases. We thank the bill’s…